A Guide to Managing CMV Risks for Cancer Patients
- Published
External source
apsense.com External website
You are viewing the Vahuk Story page. The link above opens the shared source website.
Cytomegalovirus (CMV) may sound like a rare infection, but for individuals with weakened immune systems—particularly those with cancer—it can pose serious health risks. While CMV often remains dormant in the body, certain treatments, such as chemotherapy, stem cell transplantation, or bone marrow suppression, can trigger its reactivation.
Community reactions
Karma 19.5
1
reactions
Discussion
0 comments
No comments yet. Be the first to join the discussion.